Vetsys Pharmaceutical
Vetsys Pharmaceutical
High-performance digestive stabilizers, enzymes, and systemic therapeutic formulations engineered for global markets.
Exploring the systemic shifts towards high-efficiency, biosecure, and sustainable gastrointestinal solutions in animal husbandry and industrial farming.
In modern animal production systems, the gastrointestinal tract is no longer viewed simply as an organ system for nutrient absorption. Instead, it is understood as a complex, dynamic ecosystem comprising metabolic, immunological, and microbial interfaces. As antibiotic growth promoters (AGPs) face stringent global bans, the animal health industry must pivot toward systemic digestive aids, bioactive compounds, and specialized feed enzymes. These tools sustain animal welfare while optimizing feed conversion rates (FCR).
This paradigm shift has accelerated the demand for high-purity digestive catalysts and therapeutic formulations. Industrial feed mills and veterinary systems require high-performing agents like xylanase enzymes, intestinal probiotics, and organic acids to stabilize livestock digestion under intensive management conditions. The biological and economic success of these agents rests on their thermotolerance during pelleting, their resilience against acidic gastric environments, and their precise release within the target sections of the intestinal tract.
An established industry pioneer driving research, technological innovation, and sustainable veterinary solutions since 2005.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. The facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health. Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare.
Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market. Vetsys believes that excellence in product quality is essential to long-term growth and sustainability, both for the company and the animal health industry as a whole. Our focus on quality management allows us to maintain trust and loyalty among our customers, setting us apart as a reliable partner in animal healthcare.
As part of our long-term vision, Vetsys is also committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment. In addition to our strong presence in the domestic market, Vetsys is actively exploring international expansion, aiming to bring high-quality, innovative animal health solutions to global markets. Our future strategy includes partnerships, research collaborations, and expanding our manufacturing capabilities to meet the increasing demand for safe and effective animal drugs worldwide.
Targeted biochemical interventions optimizing nutrient kinetics across livestock species and bio-industrial sectors.
Poultry and swine feed require exogenous enzymes like xylanase to break down viscous non-starch polysaccharides (NSPs). This degradation process mitigates digestal viscosity, enhances endogenous enzyme contact, and limits pathogenic bacterial proliferation in the hindgut, boosting average daily gain (ADG).
High-starch diets in dairy and beef cattle often lead to Subacute Ruminal Acidosis (SARA). The application of coarse-granule sodium bicarbonate acts as a systemic rumen buffer. It maintains physiological rumen pH ranges, stabilizing cellulolytic microflora activity and preventing systemic metabolic issues.
Applying target-released probiotics like Bacillus subtilis and Lactobacillus supports mucosal immunity. The colonization of beneficial microbes prevents pathogen adhesion, secretes natural antimicrobial peptides, and enhances intestinal villi height-to-crypt depth ratios.
Assuring compliance and quality through rigorous international certifications, tailored documentation, and local registration support.
Exporting veterinary therapeutics and bio-additives requires navigating complex regulatory systems worldwide. Vetsys mitigates compliance risks through comprehensive certification and testing portfolios. We maintain operational standards aligned with GMP, HACCP, and ISO guidelines, ensuring that every batch meets the import standards of target jurisdictions, including the EU, North America, Southeast Asia, and Latin America.
We provide complete regulatory dossiers (DMF, COA, MSDS, Stability Data) to streamline registration with local departments of agriculture and drug administrations, minimizing registration lead times.
Understanding regional feed preferences and varying ambient humidity levels, Vetsys engineers tailored coating techniques (microencapsulation) and customized moisture-barrier packaging to preserve active compound concentrations.
Our on-call veterinary specialists and technical engineers assist partners with dosage optimization, product compatibility tests in premixes, and farm-level clinical trials to maximize return on investment.
The convergence of green chemistry, synthetic biology, and precision delivery networks in the next generation of animal digestive health.
The next frontier of digestive health focuses on molecular adaptation and ecological precision. Our R&D roadmap targets the development of multi-stage release delivery systems and enzyme amalgams. These solutions remain stable during high-temperature conditioning/pelleting (up to 90°C) and activate selectively within specific intestinal segments.
By leveraging synthetic biology, Vetsys research labs study high-expression bacterial strains to optimize the efficiency of xylanase, beta-glucanase, and phytase. In parallel, our green chemistry initiatives focus on refining humic acid and sodium humate extractions from leonardite sources. This guarantees high bio-activity and organic purity, reducing heavy metal presence and environmental footprint.
Applying lipid-matrix coating methods to preserve heat-sensitive enzymes, vitamins, and probiotic cultures against gastric acids, ensuring direct release in the distal gut.
Screening and engineering extreme-environment enzymes to improve targeted catalytic efficiency, ensuring performance across various feed compositions and animal body temperatures.
Integrating solar-driven chemical recovery processes, optimized water usage loops, and bio-fermentation energy recycling to minimize production-phase carbon footprints.
Technical and procurement insights regarding feed enzyme administration, systemic buffers, and international distribution.
Xylanase enzyme granules target non-starch polysaccharides (NSPs), degrading them to reduce gut viscosity. Our granulating process uses a protective mineral core and a thermal barrier coating, allowing the enzyme to withstand standard pelleting conditions (up to 85°C) without losing activity.
It serves as an essential source of sodium and acts as a biological systemic buffer. In ruminants, it stabilizes rumen pH to prevent subacute acidosis (SARA). In poultry, it acts as an electrolyte balance restorer, particularly during heat stress when hyperventilation threatens carbonate levels.
Our intramammary infusions are manufactured in ISO-classified cleanrooms using aseptic preparation and high-vacuum homogenization. The syringes undergo terminal sterilization or validation-backed sterile filtration to guarantee purity and safety for dairy cattle.
Leonardite-extracted humic substances form a protective film over the intestinal mucosal membrane, preventing pathogen invasion. They also bind heavy metals and free-floating toxins, facilitating natural detoxification and optimizing nutrient absorption.
Yes, we provide flexible OEM/ODM formulation services. We can customize probiotic counts, combine them with herbal extracts or L-carnitine, and adjust formulation features to meet the regulatory requirements of different target countries.
Depending on formulation complexity and customization needs, standard production runs take 15 to 30 days. We ship from major ports such as Qingdao or Shanghai, offering temperature-controlled shipping and container sealing options.
Targeted veterinary treatments, systemic enzymes, and specialized chemical additives manufactured in GMP-certified facilities.
